Data Sheet Compendium, ABPI

For medicines introduced recently - as indicated by an inverted black triangle (T) in the product entry in the British National Eormulary, MIMS and the ABPI Data Sheet Compendium - doctors and hospital pharmacists are asked to report all suspected reactions. This includes any adverse or any unexpected event, however minor, which could conceivably be attributed to the medicine. Reports should be made despite uncertainty about a cause or relationship, irrespective of whether or not the reaction is well recognised and even when other medicines have been taken concurrently. (The legal position for the pharmaceutical industry requires the reporting of aU serious ADRs from the UK or other EU countries, and of all serious and unexpected ADRs from coimtries outside the EU). 

Yellow cards are also found in the back of the British National Formulary, with the ABPI Data Sheet Compendium, and interleaved with National Flealth Service General Practitioner FPIO prescription forms. 

Bristol-Myers Squibb Pharmaceuticals. Taxol (paclitaxel). ABPI Data Sheet Compendium. 1995-1996. 

Association of the British Pharmaceutical Industry (ABPI). 1999. Data sheet compendium. London Association of the British Pharmaceutical Industry. 

ABPI Data Sheet Compendium, 1998-99 p 1307. Datapharm publications, London. 

Pharmacia and Upjohn. Edronax. In ABPI compendium of data sheets and summaries of product characteristics 1998-99. London Datapharm Publications, 1998 997-998. 

ABPI Compendium of Data Sheets and Summaries of Product Characteristics 1998-1999 (For Irrigation with Peppermint Oil, See p. 981) Datapharm Publications Ltd Whitehall, London, 1998. 

ABPI Compendium of Data Sheets and Summaries of Product Characteristics CSmPCs)... 

---